Cannabidiol in anxiety disorders: current and future perspectives (2024)
- Authors:
- USP affiliated authors: GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; SIMEI, JOÃO LUÍS QUEIROZ - FMRP ; SOUZA, JOSÉ DIOGO RIBEIRO DE - FMRP ; LISBÔA, JOÃO ROBERTO FERNANDES - FMRP
- Unidade: FMRP
- DOI: 10.1016/bs.irn.2024.05.003
- Subjects: ANSIEDADE; CANABINOIDES; QUALIDADE DE VIDA; NEUROBIOLOGIA
- Language: Português
- Imprenta:
- Publisher: Academic Press
- Publisher place: London
- Date published: 2024
- Source:
- Título: International review of neurobiology: cannabidiol in neurology and psychiatry
- Volume/Número/Paginação/Ano: 334 p
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SIMEI, João Luís Queiroz et al. Cannabidiol in anxiety disorders: current and future perspectives. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: Academic Press, 2024. . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.003. Acesso em: 23 jan. 2026. -
APA
Simei, J. L. Q., Souza, J. D. R. de, Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. de S. (2024). Cannabidiol in anxiety disorders: current and future perspectives. In International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press. doi:10.1016/bs.irn.2024.05.003 -
NLM
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003 -
Vancouver
Simei JLQ, Souza JDR de, Lisboa JR, Guimarães FS, Crippa JA de S. Cannabidiol in anxiety disorders: current and future perspectives [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.003 - The use of cannabinoids in clinical psychiatry [Editorial]
- MMP-9 as a marker for the association between childhood/adolescent trauma and psychosis
- Efeitos do canabidiol na saúde mental de profissionais de saúde da linha de frente durante a pandemia de COVID-19: um estudo clínico randomizado e avaliação longitudinal
- Translational neuroscience [Editorial]: narrowing distances for future discoveries
- Prof. Elisaldo Araújo Carlini, cannabis and cannabinoids research pioneer (June 9, 1930–September 16, 2020) [Depoimento]
- The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
- Case report: cannabidiol-induced skin rash: a case series and key recommendations
- Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022)
- Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
Informações sobre o DOI: 10.1016/bs.irn.2024.05.003 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003251773.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
